Suresh Muthukumaraswamy
Dr. Suresh Muthukumaraswamy is a prominent researcher in the field of psychedelic therapy at the University of Auckland School of Pharmacy. He has been instrumental in conducting clinical trials exploring the therapeutic potential of LSD microdosing for mental health issues, particularly depression.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| New Zealand | 2 | 7.00 | 0.14% | +0% | 4,822,233 | 6,702 | $210,000 | 292$ |
| Totals | 2 | 4,822,233 | 6,702 | $210,000 | 292$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
New Zealand:
Suresh Muthukumaraswamy is leading the University of Auckland study on psychedelics.
6
New Zealand:
Dr Suresh Muthukumaraswamy is leading psychedelic research at the University of Auckland.
8